ARTICLE | Company News
Gen-Probe, Corixa marker deal
January 5, 2005 8:00 AM UTC
CRXA granted GPRO rights to IP covering genetic sequences for about 50 markers of prostate, ovarian, cervical, kidney, lung and colon cancers. GPRO will use the markers, which include AMACR for prosta...